•  
  •  
  •  
  •  

2025-09-03 12:45:48

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • NDTV Board approves Rights Issue of upto INR 400 Crore
  • Cupid Limited Robust B2B Export Order Book & Encouraging International Order Pipeline
  • PNC Infratech Ltd emerges L1 bidder for AAI tender
  • ITCONS E-Solutions Limited bags contract
  • SDHI & Indian Maritime University sign MoU to launch maritime Centres of Excellence, specialized workforce training programmes

Keywords Selected:  MEDICAMENBIOTECH

Stock Report

  • Medicamen Biotech Ltd signs distribution agreement with XGX Pharma, Denmark for 3 products
  • Medicamen Biotech Limited signs CDMO contract with XGX Pharma
  • Medicamen Biotech enters into understanding with South African business conglomerate
  • Medicamen Biotech Ltd recognized by EPSS
  • Medicamen Biotech Limited enters into manufacturing and supply agreement with US firm
  • Medicamen Biotech Ltd's facility at Bhiwadi receives final EU GMP approval from GREECE
  • Medicamen Biotech Ltd consolidated Q1FY24 PAT up at Rs. 4.17 crore
  • Shivalik Rasayan Ltd issues LOA to Medicamen Biotech Ltd to use its DMF grade Bortezomib API
  • Medicamen Biotech Ltd Q3 FY2023 consolidated profit at Rs. 3.77 crore
  • Medicamen Biotech Ltd recommends dividend of Rs. 1
  • Medicamen Biotech Ltd Q4 FY2021-22 consolidated PAT declines to Rs. 2.74 crore
  • Medicamen Biotech Q3FY22 consolidated net profit slides QoQ to Rs. 3.77 crore
  • Medicamen Biotech Ltd Q2FY22 consolidated PAT at Rs. 4.22 crore
  • Medicamen Biotech Ltd to list in NSE from Oct 27, 2021

Latest Post

  • NDTV Board approves Rights Issue of upto INR 400 Crore
  • Cupid Limited Robust B2B Export Order Book & Encouraging International Order Pipeline
  • PNC Infratech Ltd emerges L1 bidder for AAI tender
  • ITCONS E-Solutions Limited bags contract
  • SDHI & Indian Maritime University sign MoU to launch maritime Centres of Excellence, specialized workforce training programmes


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024